Physician profile
Patrick Christopher Ellis
NPI 1861401606
$7,821.25
in general payments reported to CMS, 2019-2025
14 companies · $899 in 2025
The $899 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,157 · 2020: $82.77 · 2021: $207 · 2022: $1,539 · 2023: $741 · 2024: $1,196 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,835.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,368.61 | 2019-2025 | Jot Dx, Amplatzer Amulet, Assurity |
| Boston Scientific Corporation | $3,101.46 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Heartflow, INC. | $494.15 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $208.48 | 2019-2024 | |
| Medtronic, INC. | $204.43 | 2025 | Cobalt Dr Mri Surescan, Linq II |
| Astrazeneca Pharmaceuticals LP | $178.29 | 2021-2024 | Wainua |
| Medtronic Vascular, INC. | $90.20 | 2019-2020 | |
| Amgen INC. | $75.68 | 2019 | |
| Novo Nordisk INC | $18.15 | 2020 | |
| Irhythm Technologies, INC. | $17.88 | 2024 | Zio Monitor, Zio Xt Patch |
| Merck Sharp & Dohme LLC | $17.49 | 2022 | |
| Ironshore Pharmaceuticals INC. | $16.71 | 2019 | |
| Ge Healthcare | $15.82 | 2020 | |
| Pfizer INC. | $13.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.